Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Kundan, Thind"'
Publikováno v:
Journal of Contemporary Brachytherapy, Vol 16, Iss 2, Pp 111-120 (2024)
Externí odkaz:
https://doaj.org/article/39ed465c243f4e9593c85d108cb7d768
Autor:
Kevin Martell, Conrad Bayley, Sarah Quirk, Jeremy Braun, Lingyue Sun, Wendy Smith, Harvey Quon, Kundan Thind
Publikováno v:
Radiation, Vol 3, Iss 2, Pp 87-97 (2023)
Background: Erectile dysfunction (ED) is common after prostate cancer treatment. It has been studied for conventional radiotherapy, but associations in the hypofractionated radiotherapy context are less clear. This study aimed to determine which fact
Externí odkaz:
https://doaj.org/article/e2ffead03a9c489cac3e7b79f7aa63d4
Autor:
Rutvij A. Khanolkar, Harvey Quon, Kundan Thind, Michael Sia, Michael Roumeliotis, Siraj Husain, Philip McGeachy, Tyler Meyer, Kevin Martell
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 30, Iss , Pp 38-42 (2021)
Purpose: It has previously been shown that increased wait times for prostatectomy are associated with poorer outcomes in intermediate-risk prostatic carcinoma (PCa). However, the impact of wait times on PCa outcomes following low-dose-rate brachyther
Externí odkaz:
https://doaj.org/article/eee15863bfdf47c4a5e82eec84943133
Autor:
Nina Samson, Rutvij A. Khanolkar, Sarah Quirk, Harvey Quon, Michael Roumeliotis, Alex Balogh, Michael Sia, Kundan Thind, Siraj Husain, Kevin Martell
Publikováno v:
Current Oncology, Vol 28, Iss 5, Pp 3729-3737 (2021)
Radical treatment of localized prostate cancer in elderly patients may lead to unacceptable treatment-associated toxicities that adversely impact quality of life without improving survival outcomes. This study reports on a cohort of 54 elderly (>70 y
Externí odkaz:
https://doaj.org/article/0811fcb885614aedafb4ab4d85718603
Autor:
Jean-Guy Belliveau, Kundan Thind, Robyn Banerjee, Sarah Quirk, Corinne Doll, Tien Phan, Tyler Meyer, Michael Roumeliotis
Publikováno v:
Journal of Contemporary Brachytherapy, Vol 11, Iss 2, Pp 122-127 (2019)
Externí odkaz:
https://doaj.org/article/0fa87cc3d6ae4538b028fe5f91221af9
Autor:
Kevin Martell, Soumyajit Roy, Tyler Meyer, Jordan Stosky, Will Jiang, Kundan Thind, Michael Roumeliotis, John Bosch, Steve Angyalfi, Harvey Quon, Siraj Husain
Publikováno v:
Heliyon, Vol 6, Iss 6, Pp e04092- (2020)
Purpose: To compare the outcomes of patients with intermediate risk prostate cancer (IR-PCa) treated with low-dose rate I-125 seed brachytherapy (LDR-BT) and targeted dose painting of a histologic dominant intra-epithelial lesion (DIL) to those witho
Externí odkaz:
https://doaj.org/article/86aa365e839541929465830c50d913d7
Autor:
Michael Roumeliotis, Hali Morrison, Leigh Conroy, Nathan Becker, Natalie Logie, Petra Grendarova, Kundan Thind, Andrea McNiven, Michelle Hilts, Sarah Quirk
Publikováno v:
Practical Radiation Oncology. 12:e232-e238
To develop a technology-enhanced education methodology with competency-based evaluation for radiation therapy treatment planning. The education program is designed for integration in the existing framework of Commission on Accreditation of Medical Ph
Autor:
Pedro Martinez, Elizabeth Watt, Philip McGeachy, Kevin Martell, Summit Sawhney, Kundan Thind, Siraj Husain
Publikováno v:
Journal of Applied Clinical Medical Physics
Purpose High‐dose‐rate (HDR) prostate brachytherapy is an established technique for whole‐gland treatment. For transrectal ultrasound (TRUS)‐guided HDR prostate brachytherapy, image fusion with a magnetic resonance image (MRI) can be performe
Publikováno v:
Journal of Applied Clinical Medical Physics
This study used the visualization of hypo‐intense regions on liver‐specific MRI to directly quantify stereotactic body radiation therapy (SBRT) spatial delivery accuracy. Additionally, the interfractional motion of the liver region was determined
Autor:
Arun Elangovan, Kevin Martell, Nathan Wolfe, Elizabeth Watt, Philip McGeahy, Kundan Thind, Michael Roumeliotis, Che Hsuan David Wu, Tyler Meyer, Siraj Husain
Publikováno v:
Brachytherapy. 20:58-65
Purpose The purpose of the study was to describe our approach towards safe delivery of single-fraction high-dose-rate (HDR) brachytherapy (BT) boost in patients with prostate cancer in the setting of an unshielded operating room (OR). Methods and Mat